Page 2 - Analyst Interview News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Open Orphan has 'firmly established its core pharma services offering' Proactive analyst Emma Ulker talks to Proactive London about Open Orphan (LON:ORPH).  She says ORPH has firmly established its core pharma services offering, underpinned by the world-leading quarantine facilities, unique challenge study models and its established clinical trial services.  ORPH is focusing on converting an extensive and substantial amount of non-Covid-19 related services worth over £100mln. This is in addition to substantial contracts already signed with the UK Government for COVID-19 vaccine challenge s...

TraceSafe: 'An emerging leader in the growing market for health and safety wearables' TraceSafe (CNSX:TSF) is analysed by Proactive's Ed Stacey with Presenter Katie Pilbeam.  He says wearable tech here to stay, on track for strong revenue growth for the full year 2021.  TraceSafe is an emerging leader in the growing market for health and safety wearables and the software that enables enterprises to customize and deploy these technologies.  The company recently reported revenues for the first quarter (ended March 2021) and an update on pending revenue recognition from sales already booked.

Proactive analyst Ed Stacey presents his analysis on Custodian REIT PLC (LON:CREI). The company recently announced an additional dividend for the last...

Maxcyte revenues rise 21%, hailing three new strategic licences with cell therapy developers Proactive Research analyst Emma Ulker discusses MaxCyte's (LON:MXCT) commercial momentum across its cell therapy business, which led to 21% year-on-year top-line growth to US $26.2mln in fiscal (FY) 2020.  Ulker says this included three new strategic licences with high profile cell therapy developers, a fourth signed post period, a rise in recurring revenues from instrument leases and disposable sales in cell therapy, accelerated by the receipt of milestone payments from partners.

Aurania: Dynamics dramatically altered by upsurge in gold price Mining expert Christopher Ecclestone talks to Proactive London about Aurania (CVE:ARU- OTCQB:AUIAF) after his initiation of coverage just under a year ago, now taking a look at Aurania's exploration programme and the recognition of this new district due to the successes of near neighbours such as Solaris. He says the dynamics have been dramatically altered by the upsurge in the gold price in 2020 and the copper price in 2021. And major discoveries in the vicinity (e.g. Solaris at Warintza) have electrified the district and spurre...